Jaime W. Vieser's most recent trade in Alaunos Therapeutics Inc was a trade of 6,400 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alaunos Therapeutics Inc | Jaime W. Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 6,400 | 6,400 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Jaime W. Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 3,400 | 21,159 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Jaime W. Vieser | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2025 | 250 | 250 | - | - | Series A-2 Convertible Preferred Stock | |
| Alaunos Therapeutics Inc | Jaime W. Vieser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2025 | 17,465 | 43,359 (0%) | 0% | 0 | Common Stock |